Company / Income Tax per Share
NeoGenomics Laboratories, Inc. Income Tax per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
-$0.02
FY2025
5-year range
-$0.12 / -$0.02
FY2021-FY2025
Trend
-13.8%
vs FY2024
Sector context
#146 of 160
Health Care
What the data says
Among 160 Health Care companies, NeoGenomics Laboratories, Inc. is in the top 9% for income tax per share. Income Tax per Share has fluctuated over the past 10 years, ranging from $-0.16 in FY2020 to $0.01 in FY2018.
Based on SEC 10-K filings.
-0.02 in FY2025.
Increased from $-0.07 to $-0.02 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 160This company -$0.02 Sector average $1.04
▼
-101.7% below sector average
Key checks
Key Insights
- In FY2025, income tax per share decreased 13.8% year-over-year.
- Ranks #146 out of 160 companies in the Health Care sector.
- Peak income tax per share was recorded in FY2018.
- Lowest income tax per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.02 | -13.8% |
| FY2024 | -$0.02 | +78.8% |
| FY2023 | -$0.07 | +40.1% |
| FY2022 | -$0.12 | -116.6% |
| FY2021 | -$0.06 | +65.6% |
| FY2020 | -$0.16 | -287.4% |
| FY2019 | -$0.04 | -425.5% |
| FY2018 | $0.01 | +145.1% |
| FY2017 | -$0.03 | -27.9% |
| FY2016 | -$0.02 | +30.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026